PFO
ZGNX

Pathstone Family Office’s Zogenix, Inc. ZGNX Stock Holding History

Pathstone Family Office’s Portfolio ZGNX Stock Details ZGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-175
Closed -$7K – 684
2019
Q3 		$7K Buy
+175
New +$8.07K ﹤0.01% 525

Other funds holding ZGNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Pathstone Family Office's ZGNX Position: Q4 2019 in Review

Pathstone Family Office sold out of Zogenix, Inc. (ZGNX) in Q4 2019, closing a stake of 175 shares — an estimated $7K sold.

Pathstone Family Office first reported a position in ZGNX in Q3 2019 and held it in 1 quarter. The position peaked at $7K in Q3 2019. 166 funds tracked by Wall St. Rank hold ZGNX as of Q4 2019.

  • Pathstone Family Office reported no remaining Zogenix, Inc. position as of Q4 2019 after selling out during the quarter.
  • Pathstone Family Office sold 175 Zogenix, Inc. shares in Q4 2019, an estimated $7K.
  • Pathstone Family Office first reported a position in Zogenix, Inc. in Q3 2019 and held it in 1 quarter.
  • Pathstone Family Office's Zogenix, Inc. position peaked at $7K in Q3 2019.
  • 166 funds tracked by Wall St. Rank held Zogenix, Inc. as of Q4 2019.

Based on Pathstone Family Office's 13F filing for Q4 2019, filed 14 Feb 2020.